-
OvaScience Inc (NASDAQ: OVAS) shares tumbled 50.4
percent to $1.47 after the company announced plans to reduce workforce by 30 percent and disclosed that its CEO Harald Stock is
stepping down.
-
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares
dipped 21.8 percent to $2.13 after the company reported a US$25.0 million bought deal financing.
-
Lpath Inc (NASDAQ: LPTN) shares fell 16.4 percent
to $3.05. Lpath shares have increased 11.61 percent over the past 52 weeks, while the S&P 500 index has gained 11.09
percent in the same period.
-
Red Hat Inc (NYSE: RHT) shares dropped 12.2 percent
to $70.07. Red Hat reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced
that its CFO Frank Calderoni is stepping down.
-
AAR Corp. (NYSE: AIR) shares declined 8.8 percent to
$34.27. AAR reported Q2 earnings from continuing operations of $0.35 per share on revenue of $423.8 million.
-
Zumiez Inc. (NASDAQ: ZUMZ) fell 8.6 percent to
$20.85. B. Riley downgraded Zumiez from Buy to Neutral and lowered the price target from $27.00 to $25.00.
-
Kirkland's, Inc. (NASDAQ: KIRK) dropped 8.1
percent to $15.29. B. Riley downgraded Kirkland's from Buy to Neutral.
-
GEE Group Inc (NYSE: JOB) shares slipped 8 percent
to $4.10 after the company reported consolidated financial results for the fourth quarter and fiscal year. GEE Group posted net
income of around $1 million on revenue of $21.8 million.
-
Delcath Systems, Inc. (NASDAQ: DCTH) shares fell
8 percent to $1.04. Delcath shares have tumbled 87.61 percent over the past 52 weeks, while the S&P 500 index has gained
11.09 percent in the same period.
-
Bed Bath & Beyond Inc. (NASDAQ: BBBY) declined
6.4 percent to $42.63 after the company reported weaker-than-expected results for its third quarter on Wednesday.
-
Fred's, Inc. (NASDAQ: FRED) dropped 5.6 percent
to $19.21. Fred's shares have climbed 25.23 percent over the past 52 weeks, while the S&P 500 index has gained 11.09
percent in the same period.
-
Finish Line Inc (NASDAQ: FINL) shares fell 3.8
percent to $20.21. Bank of America downgraded Finish Line from Buy to Neutral, while Canaccord Genuity downgraded the stock
from Buy to Hold.
Latest Ratings for OVAS
Date |
Firm |
Action |
From |
To |
Aug 2016 |
JP Morgan |
Maintains |
|
Neutral |
Jan 2016 |
Oppenheimer |
Downgrades |
Outperform |
Perform |
Jan 2016 |
Credit Suisse |
Initiates Coverage on |
|
Underperform |
View More Analyst Ratings for
OVAS
View the Latest Analyst Ratings
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.